Gelteq (NASDAQ:GELS) Stock Price Up 6.9% – What’s Next?

by · The Markets Daily

Gelteq Limited (NASDAQ:GELS – Get Free Report)’s share price rose 6.9% during mid-day trading on Thursday . The company traded as high as $1.35 and last traded at $1.24. Approximately 1,730,926 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 2,868,667 shares. The stock had previously closed at $1.16.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Gelteq in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on GELS

Gelteq Stock Performance

The company has a 50 day moving average price of $0.96 and a 200-day moving average price of $1.28.

Institutional Investors Weigh In On Gelteq

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP bought a new stake in shares of Gelteq Limited (NASDAQ:GELS – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq at the end of the most recent quarter.

About Gelteq

(Get Free Report)

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.

Further Reading